Lexapro (escitalopram oxalate) is indicated for the acute and maintenance treatment
of Major Depressive Disorder (MDD) in adolescents aged 12-17. Lexapro is the
second antidepressant to be approved for the treatment of MDD in adolescents, a
medical condition that affects approximately 2 million adolescents in the US.
Depression in Adolescents
Depression is a common illness in adolescents. One out of every 12 adolescents has
depression. US Preventive Services Task Force () recommends screening for adolescents.
Has your teenager been screened for depression? Use this
assessment tool with your adolescent and discuss the results with your healthcare
professional.
NEXT: WHAT IS DEPRESSION